Genmab | GEN - Trade Debtors

Stock Price
1,959.00
Daily Change
-28.50 -1.43%
Monthly
-9.56%
Yearly
41.44%
Q1 Forecast
1,920.90

Genmab reported DKK998M in Trade Debtors for its fiscal quarter ending in June of 2025.





Trade Debtors Change Date
Agios Pharmaceuticals USD 5.03M 43K Sep/2025
Almirall EUR 193.8M 20.72M Jun/2025
Amarin USD 127.31M 8.18M Sep/2025
Amgen USD 8.49B 211M Sep/2025
argenx SE USD 1.2B 289.13M Jun/2025
AstraZeneca USD 17.56B 1.32B Sep/2025
Bayer EUR 14.91B 2.73B Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Demant DKK 5.5B 262M Dec/2025
Exelixis USD 311.3M 17.42M Sep/2025
Fresenius Medical Care EUR 3.28B 43.56M Sep/2025
Galapagos EUR 77.67M 145.85M Sep/2025
Genmab DKK 998M 199M Jun/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
GN Store Nord DKK 5.29B 100M Dec/2025
GRIFOLS EUR 1.1B 155.88M Sep/2025
Hikma Pharmaceutical USD 1.11B 133M Jun/2025
Insmed USD 65.26M 10.23M Sep/2025
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.73B 182M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 100M Dec/2025
UCB EUR 1.92B 343M Jun/2025